Skip to content

A randomised controlled trial managing co-morbid depression after Acute Coronary Syndrome (ACS): MoodCare

The impact of a telephone-delivered depression management program (MOOD-CARE) on the health and depression outcomes of heart attack [Acute Coronary Syndrome (ACS)] patients compared to Usual Care

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000386235
Acronym
MOOD-CARE (Managing cO-mOrbid Depression: Coronary Aftercare Randomized Evaluation)
Enrollment
100
Registered
2009-05-29
Start date
2010-02-08
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

We will recruit ACS patients who exhibit signs of depression from six hospitals, randomise them to MOOD-CARE or usual care (UC), and follow them for up to 2 years. MOOD-CARE is a state-of-the-art telephone counselling program which has the potential to improve psychological, physical, social and vocational functioning; reduce demands on the health system; and potentially, to extend survival for the growing number of Coronary Heart Disease patients in Australia.

Interventions

MOODCARE includes up to 10 telephone counselling sessions,each approximately 30 minutes in duration, over 6 months after hospital discharge for ACS, using Cognitive Behaviour Therapy (CBT) delivered by psychologists. The sessions will be most intensive over the first 3 months when depressive symptoms are most likely to affect patients following ACS and to impact on their quality of life and adoption of secondary preventive behaviours. Psychologists will aim to reduce symptoms of depression, as w

MOODCARE includes up to 10 telephone counselling sessions,each approximately 30 minutes in duration, over 6 months after hospital discharge for ACS, using Cognitive Behaviour Therapy (CBT) delivered by psychologists. The sessions will be most intensive over the first 3 months when depressive symptoms are most likely to affect patients following ACS and to impact on their quality of life and adoption of secondary preventive behaviours. Psychologists will aim to reduce symptoms of depression, as well as improve Coronary Heart Disease (CHD) risk factors and overall Quality Of Life (QOL).

Sponsors

School of Public Health and Preventive Medicine, Monash University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
21 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

Participants include those: (i) aged 21-85; (ii) with a clinical diagnosis consistent with that of ACS (Myocardial Infarction [STEMI or non STEMI], unstable angina, by confirmed angiogram); admitted to 6 large, tertiary referral hospitals in Brisbane and Melbourne; (iii) with the ability to understand and provide written informed consent in English; (iv) with access to a telephone during the intervention period and (v) recording a Patient Health Questionnaire (PHQ9) score of 5-19

Exclusion criteria

Inability to give informed consent, patients with a life threatening illness, waiting for surgical intervention or inability to comprehend English

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 29, 2026